Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00036
http://purl.obolibrary.org/obo/dinto_DB00036
|
|---|---|
| Preferred Name | coagulation factor viia |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | coagulation factor viia
|
|---|---|
| label | coagulation factor viia
|
| DBSynonym |
proconvertin
eptacog alfa
serum prothrombin conversion accelerator
spca
coagulation factor vii precursor
|
| Definition | Recombinant human coagulation Factor VIIa (rFVIIa), intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade.1 NovoSeven is a vitamin K-dependent glycoprotein consisting of 406 amino acid residues. Cloned and expressed in hamster kidney cells, the protein is catalytically active in a two-chain form.
|
| type | |
| xref |
Drugs.com:http://www.drugs.com/cdi/coagulation-factor-viia-recombinant.html
National Drug Code Directory:0169-7010-01
UniProtKB:P08709
GenBank:M13232
Wikipedia:http://en.wikipedia.org/wiki/Factor_VII
RxList:http://www.rxlist.com/cgi/generic3/novoseven.htm
PharmGKB:PA164748389
See more
See less
|
| CASRN | 9001-25-6
|
| prefixIRI | obo2:dinto_DB00036
|
| related with | |
| DBBrand | novoseven (novo nordisk)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |